resorcinol has been researched along with Marfan Syndrome in 1 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachet, J | 1 |
Goudot, B | 1 |
Dreyfus, G | 1 |
Brodaty, D | 1 |
Dubois, C | 1 |
Delentdecker, P | 1 |
Teimouri, F | 1 |
Guilmet, D | 1 |
1 other study available for resorcinol and Marfan Syndrome
Article | Year |
---|---|
Surgery of acute type A dissection: what have we learned during the past 25 years?
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aorta; Aortic Aneurysm; Aortic Dissection | 2000 |